|
Recognising IP in Ethiopia will make availability of essential drugs easier in short notice: Officials
|
|
Shardul Nautiyal, Mumbai
November 18 , 2025
|
|
|
Recognising Indian Pharmacopoeial (IP) standards in Ethiopia will ensure drugs to be supplied at short notices, making the availability of essential drugs easier, according to officials associated with a high-level Ethiopian delegation which has arrived in India recently. The delegation is currently in Mumbai to discuss cooperation in areas of regulatory frameworks and pharmaceutical standards.
The delegation led by Frehiwot Abebe, State Minister of Health, met the Drug Controller General of India (DCGI) and the Indian Pharmacopoeia Commission (IPC) also held discussions on investment opportunities in the Indian pharmaceutical sector.
According to officials, “Recognising IP for registering/testing the quality of drugs imported from India, will enable manufacturers to produce and export drugs in huge quantities with higher batch sizes. The cost of testing would be less and the advantage of cost saving can be passed on to importing countries.”
These meetings with the Ethiopian delegation also aim to discuss strategic partnerships. The discussions also include recent reforms like the establishment of a GMP-compliant Special Economic Zone (SEZ) and streamlined regulatory processes designed to facilitate collaboration.
Going forward, the delegation will discuss structured B2B engagements, follow-up delegations, capacity-building workshops, and a roadmap for India–Ethiopia pharmaceutical cooperation.
The legal and scientific standards of IP are published at regular intervals by the IPC to assure the quality of medicinal products. Standards prescribed in the IP are authoritative in nature and are enforced by the regulatory authorities for quality control of medicines in India.
This also facilitates the exchange of information and documentation relating to the development of monographs of IP. This further enhances the ability of regulatory authorities in the provision of their services relating to or in connection with public health.
The IPC signed its first IP recognition MoU with Afghanistan in 2019, making it the first country to officially recognize the IP.
The MoUs on pharmacopoeial cooperation has earlier been signed with countries like Ghana, Nepal, Mauritius, Suriname, Nicaragua, Bhutan, Mozambique, Solomon Islands, Sri Lanka, Nauru, Malawi, Guyana, Fiji, Cuba, Maldives, Trinidad and Tobago. The latest MoU to recognise IP has been signed with Botswana on November 12, 2025 between President of India Droupadi Murmu and Advocate Duma Gideon Boko, President of the Republic of Botswana, at the Presidential Office in Gaborone, Botswana.
|
|
|
|
|
|
|
|
TOPICS
|
The Food and Drug Administration (FDA), Maharashtra, has issued a public advisory urging citizens to report any misleadi ...
|
|
|
|
|